Siti N. Hasan

Subang Jaya, Malaysia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study.

Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study.

Journal: The Lancet regional health. Western Pacific

Published: March 20, 2025

Clustering of HR + /HER2- breast cancer in an Asian cohort is driven by immune phenotypes.

Clustering of HR + /HER2- breast cancer in an Asian cohort is driven by immune phenotypes.

Journal: Breast cancer research : BCR

Published: January 16, 2024

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer.

Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer.

Journal: NPJ breast cancer

Published: August 16, 2023

Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer.

Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 10, 2022

Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.

Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.

Journal: PloS one

Published: September 12, 2021

Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation.

Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations and immune activation.

Journal: International journal of cancer

Published: July 28, 2020

The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences.

The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences.

Journal: Nature communications

Published: April 08, 2020

European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.

European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.

Journal: Nature communications

Published: November 19, 2019

A case-control study of breast cancer risk factors in 7,663 women in Malaysia.

A case-control study of breast cancer risk factors in 7,663 women in Malaysia.

Journal: PloS one

Published: March 06, 2018

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.

Journal: Journal of medical genetics

Published: July 27, 2017

Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.

Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.

Journal: Breast cancer research : BCR

Published: October 28, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026